Review article · 2025 · Open access

Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery

Nazreen Pallikkavaliyaveetil, Sriram Chandrasekaran

Advanced Drug Delivery Reviews, 229, 115762 · Published 18 December 2025 · DOI 10.1016/j.addr.2025.115762

Open full textCite this paper

In brief

“Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery” is a 2025 review article by Nazreen Pallikkavaliyaveetil and Sriram Chandrasekaran, published in Advanced Drug Delivery Reviews. OpenAlex counts 62 citations as of 16 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Advanced Drug Delivery Reviews.

Citations
62
Most cited in
2026 (62)
Field-weighted impact
3.06
References
227
Authors
2

Abstract

A critical bottleneck limiting the potential of Machine Learning (ML) and Deep Learning (DL) models within the drug discovery and development (DDD) pipeline is the scarcity of high-quality experimental data. Limited data is not an anomaly but an inherent characteristic of the DDD process. Significant financial costs, time, and confidentiality concerns limit the scale of available datasets. Applying standard ML and DL algorithms directly to these small datasets presents substantial challenges. Traditional ML models remain constrained by their dependence on handcrafted features and limited ability to capture complex biological relationships. In contrast, DL algorithms that assume data abundance are prone to overfitting and poor generalization when trained on small datasets. The small data problem thus represents a fundamental constraint that shapes the practical utility and trustworthiness of AI applications in DDD. While prior reviews have surveyed the broad landscape of AI and ML in drug discovery, a significant gap exists concerning the small data challenge across the DDD pipeline. Addressing this challenge requires adapting DL methods that typically assume data abundance, while also extending traditional ML approaches that, although well-suited to small data, remain limited in their representational capacity. This review addresses this gap by surveying key drug discovery tasks, highlighting the prevalence of limited data, and synthesizing both traditional ML methods and advanced DL strategies tailored to these contexts. By integrating methodological advances with task-specific applications, the review outlines current approaches and identifies opportunities for advancing robust, interpretable, and generalizable AI in drug discovery.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Pallikkavaliyaveetil, N., & Chandrasekaran, S. (2025). Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery. Advanced Drug Delivery Reviews, 229, 115762. https://doi.org/10.1016/j.addr.2025.115762

MLA 9

Pallikkavaliyaveetil, Nazreen, and Sriram Chandrasekaran. “Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery.” Advanced Drug Delivery Reviews, vol. 229, 2025, p. 115762. https://doi.org/10.1016/j.addr.2025.115762.

Chicago

Pallikkavaliyaveetil, Nazreen and Sriram Chandrasekaran. 2025. “Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery.” Advanced Drug Delivery Reviews 229: 115762. https://doi.org/10.1016/j.addr.2025.115762.

Harvard

Pallikkavaliyaveetil, N. and Chandrasekaran, S. (2025) ‘Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery’, Advanced Drug Delivery Reviews, 229, p. 115762. doi:10.1016/j.addr.2025.115762.

IEEE

N. Pallikkavaliyaveetil and S. Chandrasekaran, “Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery,” Advanced Drug Delivery Reviews, vol. 229, p. 115762, 2025, doi: 10.1016/j.addr.2025.115762.

BibTeX

@article{pallikkavaliyaveetil2025small,
  title     = {{Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery}},
  author    = {Pallikkavaliyaveetil, Nazreen and Chandrasekaran, Sriram},
  journal   = {Advanced Drug Delivery Reviews},
  year      = {2025},
  volume    = {229},
  pages     = {115762},
  doi       = {10.1016/j.addr.2025.115762},
  url       = {https://doi.org/10.1016/j.addr.2025.115762}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • small data
  • machine learning
  • deep learning
  • overfitting
  • generalization
  • drug discovery pipeline
  • data scarcity
  • explainable AI

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Pallikkavaliyaveetil, N., & Chandrasekaran, S. (2025). Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery. Advanced Drug Delivery Reviews, 229, 115762. https://doi.org/10.1016/j.addr.2025.115762

How many times has this paper been cited?

62 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Advanced Drug Delivery Reviews: sign in and open the full text from this page.

Who wrote this paper?

Nazreen Pallikkavaliyaveetil, Sriram Chandrasekaran.

What is the DOI of this paper?

10.1016/j.addr.2025.115762, permanently at https://doi.org/10.1016/j.addr.2025.115762. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.